Journal
ONCOGENE
Volume 28, Issue 40, Pages 3573-3585Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2009.214
Keywords
metastasis; epithelial to mesenchymal transition; proteasome inhibitor; NF-kappa B; Raf-1 kinase inhibitor protein; Snail
Funding
- NIH/NCI [CA107023-02S1, CA057152-13S1]
- Bodossaki Foundation postdoctoral fellowship
Ask authors/readers for more resources
Metastasis is associated with the loss of epithelial features and the acquisition of mesenchymal characteristics and invasive properties by tumor cells, a process known as epithelial to mesenchymal transition (EMT). Snail expression, through nuclear factor (NF)-kappa B activation, is an EMT determinant. The proteasome inhibitor, NPI-0052, induces the metastasis tumor suppressor/immune surveillance cancer gene, Raf kinase inhibitor protein (RKIP), via NF-kappa B inhibition. We hypothesized that NPI-0052 may inhibit Snail expression and, consequently, the metastatic phenotype in DU-145 prostate cancer cells. Cell treatment with NPI-0052 induced E-cadherin and inhibited Snail expression and both tumor cell invasion and migration. Inhibition of Snail inversely correlated with the induction of RKIP. The underlying mechanism of NPI-0052-induced inhibition of the metastatic phenotype was corroborated by: (1) treatment with Snail siRNA in DU-145 inhibited EMT and, in contrast, overexpression of Snail in the nonmetastatic LNCaP cells induced EMT, (2) NPI-0052-induced repression of Snail via inhibition of NF-kappa B was corroborated by the specific NF-kappa B inhibitor DHMEQ and (3) RKIP overexpression mimicked NPI-0052 in the inhibition of Snail and EMT. These findings demonstrate, for the first time, the role of NPI-0052 in the regulation of EMT via inhibition of NF-kappa B and Snail and induction of RKIP. Oncogene (2009) 28, 3573-3585; doi: 10.1038/onc.2009.214; published online 27 July 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available